InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
1
T+90 hit rate
55%
T+90 mean return
+8.2%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Stonehouse Jon P, Chairman & CEO. Director active across 2 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 32 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €298k. Activity tracked since 1 September 2021. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations32 total
15,294 sharesCommon StockSEC:0000882796-26-000039:0
631 shares@ US$8.910.0003% mcap0.2% of flowCommon StockSEC:0000882796-26-000031:0
61,793 shares@ US$7.4113.1% of flowCommon StockSEC:0000882796-25-000045:0
362,100 shares0Common StockSEC:0001127602-24-029948:0
14,010 shares@ US$7.393.3% of flowCommon StockSEC:0001127602-24-029948:1
20,000 shares0Common StockSEC:0001127602-24-029948:2
10,000 shares0Common StockSEC:0001127602-24-029948:3
10,000 shares0Common StockSEC:0001127602-24-029948:4
27,525 shares@ US$7.536.6% of flowCommon StockSEC:0001127602-24-029592:0
30,000 shares@ US$5.555.2% of flowCommon StockSEC:0001127602-24-015365:0
Ideal exit: 7 Feb 2025 (T+270)
20,000 shares0Common StockSEC:0001127602-24-000832:0
14,089 shares@ US$6.052.6% of flowCommon StockSEC:0001127602-23-030187:0
127,500 shares0Common StockSEC:0001127602-23-029835:0
25,000 shares0Common StockSEC:0001171843-23-003946:0
31,055 shares@ US$3.223.1% of flowCommon StockSEC:0001127602-23-011193:0
10,000 shares0Common StockSEC:0001127602-23-003172:0
121,452 shares0Common StockSEC:0001628280-23-000419:0
60,580 shares0Common StockSEC:0001628280-23-000354:0
127,500 shares0Common StockSEC:0001127602-22-028080:0
14,100 shares@ US$10.904.8% of flowCommon StockSEC:0001127602-22-027894:0
214,917 shares@ US$1.429.8% of flowCommon StockSEC:0001127602-22-026832:0
60,580 shares0Common StockSEC:0001628280-22-024213:0
21,054 shares0Common StockSEC:0001628280-22-024156:0
184,000 shares@ US$4.730.046% mcap50.0% of flowCommon StockSEC:0001127602-22-001458:0
184,000 shares@ US$4.7325.7% of flowCommon StockSEC:0001127602-22-001458
25 of 32 declarations
About Stonehouse Jon P
Jon P. Stonehouse is President & CEO and Director at Biocryst Pharmaceuticals Inc. As the leader of the company, he is responsible for strategic direction and management of operations. His experience in the pharmaceutical sector is an asset for Biocryst.
